Citadel Advisors’s General Moly, Inc. GMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-30,421
| Closed | -$3K | – | 11913 |
|
|
2020
Q3 | $3K | Buy |
+30,421
| New | +$5.63K | ﹤0.01% | 9977 |
|
|
2020
Q2 | – | Sell |
-57,492
| Closed | -$9K | – | 10847 |
|
|
2020
Q1 | $9K | Sell |
57,492
-47,482
| -45% | -$9.71K | ﹤0.01% | 9444 |
|
|
2019
Q4 | $24K | Buy |
+104,974
| New | +$27.3K | ﹤0.01% | 8914 |
|
|
2019
Q2 | – | Sell |
-142,495
| Closed | -$31K | – | 10184 |
|
|
2019
Q1 | $31K | Buy |
+142,495
| New | +$35K | ﹤0.01% | 8991 |
|
|
2018
Q4 | – | Sell |
-15,945
| Closed | -$6K | – | 10083 |
|
|
2018
Q3 | $6K | Sell |
15,945
-37,366
| -70% | -$14.6K | ﹤0.01% | 9127 |
|
|
2018
Q2 | $22K | Buy |
+53,311
| New | +$21.1K | ﹤0.01% | 8634 |
|
|
2018
Q1 | – | Sell |
-83,720
| Closed | -$28K | – | 9026 |
|
|
2017
Q4 | $28K | Buy |
83,720
+54,676
| +188% | +$17.4K | ﹤0.01% | 7779 |
|
|
2017
Q3 | $11K | Sell |
29,044
-2,617
| -8% | -$1.11K | ﹤0.01% | 7435 |
|
|
2017
Q2 | $12K | Buy |
31,661
+18,690
| +144% | +$6.41K | ﹤0.01% | 7364 |
|
|
2017
Q1 | $6K | Sell |
12,971
-41,259
| -76% | -$19.8K | ﹤0.01% | 7350 |
|
|
2016
Q4 | $14K | Sell |
54,230
-942
| -2% | -$245 | ﹤0.01% | 7138 |
|
|
2016
Q3 | $15K | Buy |
55,172
+1,250
| +2% | +$398 | ﹤0.01% | 7114 |
|
|
2016
Q2 | $19K | Buy |
+53,922
| New | +$19.5K | ﹤0.01% | 6632 |
|
|
2016
Q1 | – | Sell |
-97,101
| Closed | -$19K | – | 8493 |
|
|
2015
Q4 | $19K | Buy |
97,101
+71,008
| +272% | +$19.4K | ﹤0.01% | 7982 |
|
|
2015
Q3 | $8K | Sell |
26,093
-1,470
| -5% | -$717 | ﹤0.01% | 8546 |
|
|
2015
Q2 | $20K | Sell |
27,563
-11,332
| -29% | -$8.06K | ﹤0.01% | 8162 |
|
|
2015
Q1 | $20K | Buy |
38,895
+8,343
| +27% | +$4.25K | ﹤0.01% | 7917 |
|
|
2014
Q4 | $17K | Buy |
+30,552
| New | +$17.2K | ﹤0.01% | 7926 |
|
|
2014
Q3 | – | Sell |
-1,266
| Closed | -$1K | – | 8549 |
|
|
2014
Q2 | $1K | Buy |
+1,266
| New | +$1.32K | ﹤0.01% | 7899 |
|
|
2014
Q1 | – | Sell |
-14,520
| Closed | -$19K | – | 8101 |
|
|
2013
Q4 | $19K | Sell |
14,520
-1,614
| -10% | -$2.32K | ﹤0.01% | 6500 |
|
|
2013
Q3 | $27K | Sell |
16,134
-82,468
| -84% | -$149K | ﹤0.01% | 6080 |
|
|
2013
Q2 | $185K | Buy |
+98,602
| New | +$194K | ﹤0.01% | 4737 |
|
Other funds holding GMO
Citadel Advisors's GMO Position: Q4 2020 in Review
Citadel Advisors sold out of General Moly, Inc. (GMO) in Q4 2020, closing a stake of 30,421 shares — an estimated $3K sold.
Citadel Advisors first reported a position in GMO in Q2 2013 and held it in 22 quarters. The position peaked at $185K in Q2 2013. 7 funds tracked by Wall St. Rank hold GMO as of Q4 2020.
- Citadel Advisors reported no remaining General Moly, Inc. position as of Q4 2020 after selling out during the quarter.
- Citadel Advisors sold 30,421 General Moly, Inc. shares in Q4 2020, an estimated $3K.
- Citadel Advisors first reported a position in General Moly, Inc. in Q2 2013 and held it in 22 quarters.
- Citadel Advisors's General Moly, Inc. position peaked at $185K in Q2 2013.
- 7 funds tracked by Wall St. Rank held General Moly, Inc. as of Q4 2020.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.